Target
Peroxisome proliferator-activated receptor gamma
Ligand
BDBM50166295
Substrate
n/a
Meas. Tech.
ChEMBL_310661 (CHEMBL838008)
EC50
3±n/a nM
Citation
 Liu, KBlack, RMActon, JJMosley, RDebenham, SAbola, RYang, MTschirret-Guth, RColwell, LLiu, CWu, MWang, CFMacNaul, KLMcCann, MEMoller, DEBerger, JPMeinke, PTJones, ABWood, HB Selective PPARgamma modulators with improved pharmacological profiles. Bioorg Med Chem Lett 15:2437-40 (2005) [PubMed]  Article 
Target
Name:
Peroxisome proliferator-activated receptor gamma
Synonyms:
NR1C3 | Nuclear receptor subfamily 1 group C member 3 | PPAR-gamma | PPARG | PPARG_HUMAN | Peroxisome proliferator-activated receptor | Peroxisome proliferator-activated receptor gamma (PPAR gamma) | Peroxisome proliferator-activated receptor gamma (PPARG) | Peroxisome proliferator-activated receptor gamma (PPARĪ³) | Peroxisome proliferator-activated receptor gamma/Nuclear receptor corepressor 2 | peroxisome proliferator-activated receptor gamma isoform 2
Type:
Nuclear Receptor
Mol. Mass.:
57613.46
Organism:
Homo sapiens (Human)
Description:
P37231
Residue:
505
Sequence:
MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY
  
Inhibitor
Name:
BDBM50166295
Synonyms:
(R)-2-{4-Chloro-3-[1-(6-methoxy-benzo[d]isoxazol-3-yl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid | CHEMBL364894
Type:
Small organic molecule
Emp. Form.:
C28H22ClF3N2O6
Mol. Mass.:
574.932
SMILES:
COc1ccc2c(noc2c1)-n1c(C)c(Cc2cc(O[C@H](C)C(O)=O)ccc2Cl)c2cc(OC(F)(F)F)ccc12 |wD:20.22,(29.61,-7.83,;29.61,-6.29,;28.28,-5.52,;28.28,-3.99,;26.95,-3.22,;25.63,-3.99,;24.17,-3.51,;23.28,-4.76,;24.18,-5.99,;25.63,-5.52,;26.95,-6.28,;23.7,-2.06,;24.59,-.82,;26.14,-.82,;23.7,.43,;24.17,1.91,;25.67,2.23,;26.71,1.11,;28.2,1.44,;29.24,.28,;30.75,.6,;31.22,2.06,;31.78,-.54,;31.31,-2.01,;33.29,-.22,;28.68,2.9,;27.65,4.04,;26.15,3.72,;25.11,4.84,;22.23,-.03,;20.89,.74,;19.55,-.05,;18.2,.74,;16.86,-.05,;17.65,-1.38,;15.53,-.84,;16.08,1.3,;19.55,-1.58,;20.89,-2.36,;22.23,-1.58,)|
Structure:
Search PDB for entries with ligand similarity: